Investigational drugs for the treatment of Covid-19

The adverse reactions of the following drugs and classes of drugs, which are under consideration or investigation for the treatment of patients with Covid-19, are searchable in Litt’s Drug Eruption & Reaction Database.

Other drugs developed before the emergence of Covid-19 (e.g. Remdesvir) are also under investigation for treating this disease, but are not yet approved by the FDA for other indications and therefore are not included in the Litt database.